Jean-Jacques Bienaim
2021
Compensation breakdown
| Non-Equity Incentive Plan | $2,343,600 |
|---|---|
| Option Awards | $3,247,040 |
| Salary | $1,260,000 |
| Stock Awards | $11,342,306 |
| Other | $62,492 |
| Total | $18,255,438 |
Bienaim received $11.3M in stock awards, accounting for 62% of the total pay in 2021.
Bienaim also received $2.3M in non-equity incentive plan, $3.2M in option awards, $1.3M in salary and $62.5K in other compensation.
Rankings
In 2021, Jean-Jacques Bienaim's compensation ranked 384th out of 12,415 executives tracked by ExecPay. In other words, Bienaim earned more than 96.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 384 out of 12,415 | 97th |
Division Manufacturing | 119 out of 5,505 | 98th |
Major group Chemicals And Allied Products | 36 out of 2,375 | 99th |
Industry group Drugs | 32 out of 2,096 | 99th |
Industry Pharmaceutical Preparations | 18 out of 1,546 | 99th |
Pay ratio
| Jean-Jacques Bienaim's Pay | $18,255,438 |
|---|---|
| Median Employee's Pay | $175,523 |
| Pay Ratio | 104to 1 |
In 2021, the annual total compensation of Jean-Jacques Bienaim was $18,255,438.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $175,523.
The ratio of Jean-Jacques Bienaim's pay to the pay of median employee was therefore 104 to one.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2021.
2021
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2021
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2021
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2021
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019